Dapoxetine: Effective On-Demand Treatment for Premature Ejaculation
| Product dosage: 30mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.01 | $40.12 (0%) | 🛒 Add to cart |
| 20 | $3.01 | $80.24 $60.18 (25%) | 🛒 Add to cart |
| 30 | $2.67 | $120.36 $80.24 (33%) | 🛒 Add to cart |
| 60 | $1.67 | $240.71 $100.30 (58%) | 🛒 Add to cart |
| 90 | $1.45 | $361.07 $130.39 (64%) | 🛒 Add to cart |
| 120 | $1.34 | $481.42 $160.47 (67%) | 🛒 Add to cart |
| 180 | $1.23 | $722.13 $220.65 (69%) | 🛒 Add to cart |
| 270 | $1.08 | $1083.20 $290.86 (73%) | 🛒 Add to cart |
| 360 | $0.95
Best per pill | $1444.27 $341.01 (76%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.51 | $45.13 (0%) | 🛒 Add to cart |
| 20 | $3.76 | $90.27 $75.22 (17%) | 🛒 Add to cart |
| 30 | $3.01 | $135.40 $90.27 (33%) | 🛒 Add to cart |
| 60 | $2.01 | $270.80 $120.36 (56%) | 🛒 Add to cart |
| 90 | $1.67 | $406.20 $150.44 (63%) | 🛒 Add to cart |
| 120 | $1.59 | $541.60 $190.56 (65%) | 🛒 Add to cart |
| 180 | $1.45 | $812.40 $260.77 (68%) | 🛒 Add to cart |
| 270 | $1.30 | $1218.60 $351.04 (71%) | 🛒 Add to cart |
| 360 | $1.20
Best per pill | $1624.80 $431.27 (73%) | 🛒 Add to cart |
| Product dosage: 90mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $5.01 | $50.15 (0%) | 🛒 Add to cart |
| 20 | $4.51 | $100.30 $90.27 (10%) | 🛒 Add to cart |
| 30 | $4.35 | $150.44 $130.39 (13%) | 🛒 Add to cart |
| 60 | $3.68 | $300.89 $220.65 (27%) | 🛒 Add to cart |
| 90 | $3.34 | $451.33 $300.89 (33%) | 🛒 Add to cart |
| 120 | $3.09 | $601.78 $371.10 (38%) | 🛒 Add to cart |
| 180 | $2.79 | $902.67 $501.48 (44%) | 🛒 Add to cart |
| 270 | $2.04 | $1354.00 $551.63 (59%) | 🛒 Add to cart |
| 360 | $1.67
Best per pill | $1805.34 $601.78 (67%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSI) specifically developed for the on-demand treatment of premature ejaculation (PE) in adult men. It represents a significant advancement in urological and sexual medicine, offering a pharmacologically targeted approach to a common and often distressing condition. By modulating serotonin neurotransmission, dapoxetine helps to increase intravaginal ejaculatory latency time (IELT) and improve perceived control over ejaculation. Its rapid absorption and elimination profile make it uniquely suited for use as needed, rather than as a continuous daily medication.
Features
- Chemical Entity: Dapoxetine hydrochloride.
- Pharmacological Class: Selective Serotonin Reuptake Inhibitor (SSRI).
- Mechanism of Action: Potent inhibition of the serotonin transporter, increasing serotonin activity in the synaptic cleft within the central nervous system, which is involved in the neurobiological control of ejaculation.
- Dosage Forms: Available in film-coated tablet formulations.
- Strengths: Typically available in 30 mg and 60 mg doses.
- Pharmacokinetics: Characterized by rapid absorption (Tmax of approximately 1-2 hours) and a short elimination half-life (approximately 1.5-2 hours).
- Prescription Status: A prescription-only medication, requiring diagnosis and supervision by a qualified healthcare professional.
Benefits
- Significantly Increases Ejaculatory Latency: Clinical trials demonstrate a substantial, 3-4 fold geometric mean increase in intravaginal ejaculatory latency time (IELT) compared to placebo.
- Enhances Perceived Control: Users report a greater sense of voluntary control over the ejaculatory reflex, reducing anxiety associated with sexual performance.
- Improves Sexual Satisfaction: Leads to improvements in both personal sexual satisfaction and satisfaction within the relationship, as measured by validated patient-reported outcome tools like the PEP and ISSQ.
- On-Demand Dosing Convenience: Its pharmacokinetic profile allows for dosing approximately 1-3 hours before anticipated sexual activity, eliminating the need for daily medication and associated long-term side effects.
- Evidence-Based Efficacy: Supported by a robust body of clinical evidence from randomized, double-blind, placebo-controlled studies involving thousands of patients.
Common use
Dapoxetine is indicated for the treatment of premature ejaculation (PE) in adult men aged 18 to 64 years. PE is a multifactorial condition defined by the International Society for Sexual Medicine (ISSN) by three key criteria: 1) An ejaculation that always or nearly always occurs prior to or within about one minute of vaginal penetration (lifelong PE) or a clinically significant reduction in latency time, often to about three minutes or less (acquired PE); 2) The inability to delay ejaculation on all or nearly all vaginal penetrations; and 3) Negative personal consequences, such as distress, bother, frustration, and/or the avoidance of sexual intimacy. Dapoxetine is intended for patients who meet these diagnostic criteria.
Dosage and direction
The recommended starting dose is 30 mg, taken orally as a single dose approximately 1 to 3 hours before anticipated sexual activity. It must be swallowed whole with at least a full glass of water. The dose may be increased to 60 mg based on efficacy and tolerability. It is not recommended to take more than one dose within a 24-hour period. Dapoxetine can be taken with or without food; however, a high-fat meal may delay absorption and reduce maximum plasma concentration, which could potentially diminish efficacy. The need for continued treatment should be reassessed by a physician periodically (e.g., every 6 months).
Precautions
- Dapoxetine must not be used in combination with other SSRIs, SNRIs, monoamine oxidase inhibitors (MAOIs), thioridazine, or other serotonergic drugs due to the risk of serotonin syndrome.
- It is associated with orthostatic hypotension (a drop in blood pressure upon standing), which may lead to syncope (fainting) or pre-syncope (dizziness). Patients should be advised to rise slowly from a sitting or lying position.
- Use with caution in patients with underlying cardiovascular conditions, including those with a history of syncope, and in patients taking concomitant medications that can lower blood pressure.
- Caution is advised in patients with a history of mania or hypomania, as SSRIs can potentially induce these states.
- Patients should be monitored for the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, and mania.
- As with other SSRIs, discontinuation symptoms (e.g., dizziness, nausea, irritability) may occur upon abrupt cessation, though the risk is lower due to the drug’s short half-life and intermittent dosing.
Contraindications
- Hypersensitivity to dapoxetine or any of the excipients in the formulation.
- Concomitant administration with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing an MAOI. Similarly, dapoxetine must not be administered within 7 days of discontinuing treatment with a potent CYP3A4 inhibitor.
- Concomitant administration with other central serotonergic drugs (e.g., SSRIs, SNRIs, tricyclic antidepressants, tramadol, tryptans, lithium, St. John’s Wort) due to the risk of serotonin syndrome.
- Concomitant administration with thioridazine.
- Patients with a history of mania or severe depression.
- Patients with significant pathological cardiac conditions such as heart failure (NYHA Class II-IV), conduction abnormalities (e.g., sick sinus syndrome, sinoatrial or AV block), significant ischemic heart disease, or significant valvular disease.
- Patients with moderate or severe hepatic impairment.
Possible side effect
The most commonly reported adverse reactions are dose-dependent and are often related to its SSRI mechanism or autonomic effects. They are typically mild to moderate and transient.
- Very Common (≥1/10): Nausea, dizziness, headache.
- Common (≥1/100 to <1/10): Diarrhea, insomnia, somnolence (sleepiness), fatigue, tremor, anxiety, blurred vision, vomiting, abdominal pain, flushing, increased sweating, dry mouth, tachycardia, palpitations, vertigo, hypertension.
- Uncommon (≥1/1,000 to <1/100): Syncope (fainting), attention disturbance, tinnitus, euphoric mood, erection increased, dyspnea, feeling jittery, chest tightness, irritability, confusion, paresthesia (tingling sensation), mydriasis (pupil dilation), eye pain, eye swelling, priapism (prolonged erection).
- As with all SSRIs, rare cases of serotonin syndrome, suicidal ideation, and seizures have been reported.
Drug interaction
Dapoxetine is primarily metabolized by multiple CYP enzymes, including CYP3A4, CYP2D6, and others, leading to several important interactions.
- Potent CYP3A4 Inhibitors (e.g., ketoconazole, itraconazole, ritonavir, clarithromycin): Contraindicated. They significantly increase dapoxetine exposure.
- Moderate CYP3A4 Inhibitors (e.g., erythromycin, fluconazole, diltiazem): Concomitant use is not recommended. If unavoidable, the maximum dose should be limited to 30 mg.
- Potent CYP2D6 Inhibitors (e.g., fluoxetine, paroxetine): May increase dapoxetine exposure. Caution is advised.
- CYP3A4 Inducers (e.g., rifampicin, phenytoin, carbamazepine, St. John’s Wort): May decrease dapoxetine exposure and reduce efficacy.
- Other Serotonergic Drugs: Contraindicated with MAOIs, other SSRIs, SNRIs, and tramadol. Use with triptans and tricyclic antidepressants requires extreme caution.
- Alcohol: Concomitant use is not recommended. Alcohol may increase the risk of adverse events such as dizziness, drowsiness, and slowed judgment, and may increase the risk of syncope.
- Drugs that Lower Blood Pressure or Heart Rate: May have additive effects with dapoxetine, increasing the risk of dizziness, hypotension, and syncope. This includes alpha-blockers (e.g., tamsulosin) used for BPH, and moderate-to-strong antihypertensives.
Missed dose
Dapoxetine is not intended for daily scheduled use. It is taken only on an as-needed basis prior to anticipated sexual activity. Therefore, the concept of a “missed dose” does not apply. The patient should simply take the next dose when needed, following the same dosing instructions (1-3 hours beforehand). Do not take a double dose to make up for a missed opportunity.
Overdose
In the event of a suspected overdose (e.g., ingestion of more than the recommended 60 mg maximum dose in 24 hours), symptomatic and supportive measures should be initiated immediately. There is no specific antidote for dapoxetine overdose. Symptoms are expected to be an exaggeration of its known adverse effects, including but not limited to: serotonin syndrome (agitation, confusion, diaphoresis, tachycardia, hyperthermia, hyperreflexia), dizziness, nausea, vomiting, somnolence, and syncope. Due to the risk of serious cardiovascular events, such as syncope, patients should be referred for immediate medical evaluation, which may include ECG monitoring. Gastric lavage and administration of activated charcoal may be considered if presented early.
Storage
- Store below 30°C (86°F).
- Keep the tablets in their original blister pack to protect from light and moisture.
- Keep out of the sight and reach of children.
- Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is not intended to recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information.
Reviews
- “As a urologist with a special interest in male sexual health, dapoxetine has been a valuable addition to our treatment armamentarium. Its on-demand nature and proven efficacy in increasing IELT make it a first-line pharmacological option for many of my patients with lifelong PE. Patient satisfaction, particularly regarding improved control, is consistently high.” – Dr. A. Sharma, MD, Urology.
- “The clinical trial data for dapoxetine is robust and convincing. It fills a specific niche that daily SSRIs, with their long onset of action and different side effect profile, do not. The key is proper patient selection and thorough education on potential side effects like dizziness to ensure safe use.” – Clinical Pharmacologist, Pharma Industry.
- “From a psychiatric perspective, it’s crucial to differentiate PE from other sexual dysfunctions that may be rooted in anxiety or depression. For appropriately diagnosed patients, dapoxetine offers a targeted solution. We remain vigilant for any mood-related side effects, as with any agent affecting serotonin.” – Dr. L. Chen, Psychiatrist.
- “The short half-life is a double-edged sword. It allows for on-demand use but also means the window for efficacy is quite specific. Patient education on timing is paramount for success. The interactions with common medications, especially antifungals and some antibiotics, require careful medication history review.” – Primary Care Physician.